lithium has been researched along with ticlopidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baqi, Y; Carlson, NG; Heiney, KM; Kishore, BK; Kohan, DE; Müller, CE; Peti-Peterdi, J; Strasburg, DL; Villanueva, K; Zhang, Y | 1 |
| Carlson, NG; Ecelbarger, CM; Heiney, KM; Kishore, BK; Müller, CE; Peti-Peterdi, J; Riquier-Brison, A; Zhang, Y | 1 |
2 other study(ies) available for lithium and ticlopidine
| Article | Year |
|---|---|
P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Clopidogrel; Deamino Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Kidney Concentrating Ability; Kidney Medulla; Kidney Tubules, Collecting; Lithium; Male; Purinergic P2Y Receptor Antagonists; Rats; Rats, Brattleboro; Rats, Sprague-Dawley; Receptors, Purinergic P2Y12; RNA, Messenger; Ticlopidine; Water | 2015 |
Clopidogrel attenuates lithium-induced alterations in renal water and sodium channels/transporters in mice.
Topics: Aldosterone; Animals; Aquaporin 2; Aquaporins; Arginine Vasopressin; Body Water; Clopidogrel; Dinoprostone; Epithelial Sodium Channels; Kidney; Lithium; Male; Mice; Platelet Aggregation Inhibitors; Polyuria; Receptors, Purinergic P2Y12; Sodium Channels; Solute Carrier Family 12, Member 1; Ticlopidine | 2015 |